Although there are in vitro studies suggesting anti-proliferative and pro-apoptotic functions of NAG-1 in cancers of colon, breast and prostate (7), a number of studies have shown that NAG-1 is involved in progression of breast, gastric, prostate and colorectal carcinomas (8–11). Here, GDF15 is linked to colorectal carcinoma.